Latigobio
An Associate Director, Clinical Operations (Late-Phase) leads the execution of late-phase clinical trials, develops operational strategies, manages vendor performance, and ensures compliance with regulatory standards.
Latigo Biotherapeutics is a biopharmaceutical company focused on developing non‑opioid therapies to relieve pain and restore health. Their approach targets the source of pain before it reaches the central nervous system, aiming to prevent chronic pain rather than merely dull symptoms. Latigo’s solutions are designed to enable healing without dependence and to provide durable relief that can help restore patients’ quality of life.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Latigobio.
Latigobio didn’t post a salary, so this is our estimate from similar listings.
Medical Director - Late Phase Research
Florida Cancer Specialists & Research Institute
Late Phase Senior Clinical Program Manager, Clinical Operations – Medical Affairs
Revolution Medicines
Clinical Trials Manager- Late Phase Oncology (Office-Based)
Gilead Sciences
Late Phase Program Manager, Clinical Operations - Medical Affairs
Revolution Medicines
Clinical Trials Manager- Late Phase Oncology
Gilead Sciences
Principal Biostatistician FSP, Late Phase
lifelancer